Senior Biomedical Scientist | Barts Health NHS Trust
| Posting date: | 26 February 2026 |
|---|---|
| Salary: | Not specified |
| Additional salary information: | £56,276 - £63,176 Per annum inc |
| Hours: | Full time |
| Closing date: | 02 April 2026 |
| Location: | London, E1 1FR |
| Company: | Barts Health NHS Trust |
| Job type: | Permanent |
| Job reference: | 7836948/259-7836948ESEL |
Summary
An exciting opportunity has arisen in Haematology & Blood Transfusion within the NHS East and South East London Pathology Partnership (ESEL). A new organisation, jointly owned by Barts Health NHS Trust, Homerton University Hospital NHS Foundation Trust, and Lewisham and Greenwich NHS Trust, ESEL offers high-quality, cost-effective pathology services across a network of 7 hospital laboratories. The Royal London Hospital (RLH), a major trauma centre, is the primary location for Blood Transfusion services, connected to partner hospitals such as St. Bartholomew, Whipps Cross, Newham, Homerton, Lewisham, and Queen Elizabeth.
We are seeking a proactive, driven Band 7 Senior Specialist Biomedical Scientist to join our team at RLH. The role will focus on improving service delivery and quality in Haematology and Transfusion, with collaboration across the Pathology Partnership. While the primary site is RLH, work locations may change based on service demand.
Applicants must be HCPC-registered and hold an MSc in Biomedical Science or IBMS Special Examination (Fellowship). Candidates working towards their MSc and showing exceptional potential may be considered, with support to complete the qualification at Greenwich University.
If you require further information or would like to arrange an informal visit please contact:
Mrs Minal Dave – Haematology and Coagulation Operational Lead
Tel 0203 246 0409
Email – minal.dave3@nhs.net
Barts Health is the host trust to the Partnership and all Partnership staff are employed by Barts Health. The Partnership carries out over 38m tests per year, has 860 funded WTE staff and a budget of £121m (June 2025).
The Pathology Partnership is governed through its Strategic Management Board, comprising of an independent Chair, five directors from the Partnership and six executive director representatives from the owner Trusts. Each Trust has a single vote for decision making.
In addition to the Chief Executive and Finance Director, the Partnership has three other directors who are the Clinical Director, Operations Director and Quality and Improvement Director.
The Partnership runs laboratories at:
1. Homerton Hospital
2. Newham Hospital
3. Queen Elizabeth Hospital
4. Royal London Hospital
5. St Bartholomew’s Hospital
6. University Hospital Lewisham
Whipps Cross Hospital
The Partnership is based on a well-established hub and satellite model for pathology networks, with the Royal London Hospital being the main hub laboratory for the network and Essential Service Laboratories (ESL) as a minimum at all other Hospital sites.
The Partnership was set up in May 2021 and has undertaken a complex three year transformation programme to establish the hub and spoke model, underpinned by a single, shared IT system and single, shared Quality Management System. Another Trust may be joining the Partnership in the future.
The Partnership is organised into three Operational divisions:
The NHS East and South East London Pathology Partnership is an arms-length organisation providing pathology services to Barts Health NHS Trust, Homerton Healthcare NHS Foundation Trust and Lewisham and Greenwich NHS Trust. The Pathology Partnership is hosted by Barts Health.
The Pathology Partnership was formed in May 2021. Between 2021 and 2024 the Partnership undertook a complex transformation programme to establish a single network of laboratories, underpinned by a single Laboratory Information Management System (LIMS) and single Quality Management System (QMS).
The Partnership has a main hub laboratory at the Royal London Hospital and Essential Service Laboratories (ESL) as a minimum at the six other hospital sites served by the Partnership.
The Partnership has three operational divisions:
· Blood Sciences including Haematology, Blood Transfusion and Biochemistry
· Microbiology and Virology
· Cellular Pathology and Cancer Diagnostics
The 2024/25 total operating costs across the Partnership were c. £121m per annum with a workforce establishment of circa. 860 WTE.
We strive to live by ourWeCarevalues and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.
We are dedicated to being an outstanding place to work and will work with you to get the best experience. We know flexible working is not a one size fits all and will mean something different to everyone. We are inclusive, so if you are interested in flexible working, please speak to the recruiting manager.
The full job description provides an overview of the key tasks and responsibilities of the role, and the person specification outlines the qualifications, skills, experience, and knowledge required. For both documents, please view the attachment/s below.
This advert closes on Sunday 15 Mar 2026